Therapeutic Asset Ratings
9,928 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cis-Diamminedichloroplatinum Ii
Head And Neck Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Penile Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Alveolar Soft Part Sarcoma
Taiho Pharmaceutical Co., Ltd.
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Urinary Bladder Small Cell Neuroendocrine Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Skin Squamous Cell Carcinoma
Seagen, a wholly owned subsidiary of Pfizer
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Appendix Adenocarcinoma
City of Hope Medical Center
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Prostate Neuroendocrine Neoplasm
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Prostate Small Cell Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Uterine Corpus Endometrial Carcinoma
City of Hope Medical Center
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
SMARCA4-Deficient Sarcoma Of Thorax
Eli Lilly and Company
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Distal Biliary Tract Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Intrahepatic Bile Duct Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Penile Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Uterine Corpus Cancer
City of Hope Medical Center
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Appendix Carcinoma
City of Hope Medical Center
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Stage IVb Bladder Cancer
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Ureter Small Cell Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Cladribine
Acute Undifferentiated Leukemia
Fred Hutchinson Cancer Center
P1
CC
(43)
Claturafenib
Colorectal Cancer
Pfizer
P1
CC
(43)
Claturafenib
Brain Neoplasm
Pfizer
P1
CC
(43)
Claturafenib
Differentiated Thyroid Carcinoma
Pfizer
P1
CC
(43)
Claturafenib
Malignant Glioma
Pfizer
P1
CC
(43)
Claturafenib
Low Grade Glioma
Pfizer
P1
CC
(43)
Claturafenib
Cancer
Pfizer
P1
CC
(43)
Claudin 18.2 Car-T
Ovarian Carcinoma
Suzhou Immunofoco Biotechnology Co., Ltd
P1
CC
(43)
Showing 1651 to 1675 of 9,928 assets
Previous
Page 67 of 398
Next
